Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kai Krohn is active.

Publication


Featured researches published by Kai Krohn.


AIDS | 1992

Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies.

Ovod; Anssi Lagerstedt; Annamari Ranki; Frank Otto Gombert; Spohn R; Maria Tähtinen; Günther Jung; Kai Krohn

ObjectiveTo study the immunological and immunohistochemicai nature of HIV-1 Nef. DesignMonoclonal anti-Nef antibodies were generated and used to identify antigenic epitopes in Nef, to study immunological cross-reactivity between Nef from different isolates and to reveal the subcelluiar localization of Nef. MethodsMonoclonal antibodies against recombinant HIV-1 Nef protein (BRU isolate) were generated in BALB/c mice. The epitope mapping was carried out with the use of overlapping 15–20mer lipopeptides linked to a lipid group at the amino-terminus. Immunoperoxidase method was used for histochemical studies. ResultsTen stable antibody-producing clones, mainly of the immunoglobulin (Ig) G1 subtype, with strong Western blot and enzyme-linked immunosorbent assay reactivity toward the recombinant Nef protein, were obtained. The epitopes recognized were located on amino-acid sequences 21–41, 31–50, 51–71, 61–80, 151–170, 161–180, and 171–190. All 10 monoclonal antibodies also reacted with the native Nef of HIV-1BRU, and eight reacted with native HIV-1IIIB. Most antibodies also reacted with Nef from more divergent HIV-1 strains. In Western blotting, two forms of Nef (24 and 27 kDa) were observed with most isolates studied. Immunohistochemical staining of HIV-1 -infected H9 or MT-4 lymphoid cells demonstrated that Nef was expressed mainly in the Golgi complex and at the nuclear membrane, but occasionally also in the nucleus. The nuclear localization of Nef was especially frequent in the HIV-1-infected MT-4 cells. ConclusionsOur findings suggest that Nef is expressed in two isomorphic forms, and that it may also act as a nuclear protein and thus have a direct regulatory function at the RNA/DNA level.


Acta Paediatrica | 1971

Intensive care of small premature infants. II. Postmortem findings.

Eero K. Vapaavuori; Kai Krohn

Twenty‐seven deaths in premature infants weighing less than 1 250 g who were treated with intermittent positive pressure respiration are reported. The major pulmonary abnormalities were hyaline membrane formation, infection, and hemorrhage occurring‘ alone or in combination with intraverticular hemorrhage. Hyaline membranes were associated with severe clinical features of respiratory distress, whereas infection was not. Prolonged treatment resulted in “bronchopulmonary dysplasia” in only 1 case where severe clinical respiratory distress was associated with the finding of hyaline membranes at post mortem.


Endocrine connections | 2013

Absence of some common organ-specific and non-organ-specific autoimmunity in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy

Nicolas Kluger; Kai Krohn; Annamari Ranki

Background Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) is a rare autosomal recessive disorder caused by mutations of the autoimmune regulator (AIRE) gene, whose loss of function leads to the escape of self-reactive T cells from the thymus and autoimmunity. APECED patients typically develop tissue-specific autoantibodies and anti-cytokine antibodies. Consequently, various endocrine and non-endocrine autoimmune disorders appear. However, only a certain number of autoimmune diseases develop, while some common autoimmune conditions have not been reported or are seen only anecdotally. Objective We investigated the clinical manifestations and occurrence of antinuclear antibodies (AN-Abs) and antibodies against extractable nuclear antigens, citrullinated peptide, and transglutaminase in 24 patients and against bullous pemphigoid antigen 180 and desmogleins 1 (Dsg1) and Dsg3 in 30 patients of a Finnish cohort of APECED patients. Results Despite the loss of central tolerance, the autoantibodies investigated were not overrepresented among the APECED patients. None of the patients had a history of autoimmune connective tissue disease, rheumatoid arthritis, celiac disease, or autoimmune cutaneous bullous disorders. Altogether, 25% (6/24) had low-titer (1:80) AN-Abs. Two patients had anti-BP180 antibodies and two others had anti-Dsg3 antibodies without any cutaneous or mucosal symptoms. No anti-citrullinated peptide and anti-transglutaminase reactivity was found. Conclusions The mechanisms that drives tolerance to tissue autoantigens is not fully understood as even APECED patients, who are genetically prone to develop autoantibodies, are tolerant against some common autoantigens. The hypothesis that some of the anti-cytokine antibodies commonly found in APECED patients may be protective should be investigated in larger series.


Clinical Immunology and Immunopathology | 1974

Precipitating anti-adrenal antibodies in Addison's disease

Kai Krohn; Jaakko Perheentupa; Erkki Heinonen

Abstract Precipitating antibodies that react against two tissue-specific adrenal antigens were found in 9 out of 19 children suffering from moniliasis and hypoparathyroidism. Eleven of these children had, or developed, adrenal failure during the course of the study. The antibodies were of IgG type with a narrow electrophoretic mobility. Immunofluorescence revealed adrenal antibodies in all of the cases with precipitating antibodies, in five additional cases with moniliasis and hypoparathyroidism, and in two children with Addisons disease alone. Correlation of clinical and immunological data suggest that the presence of precipitating adrenal antibodies may be characteristic of the moniliasis-hypoparathyroidism complex and that in this disease group, adrenal antibodies frequently precede the manifestation of adrenal failure.


Acta Obstetricia et Gynecologica Scandinavica | 1970

A Microangiography Study of the Fetal Arterial Vasculature in the Human Placenta in Uncomplicated Pregnancy

Kai Krohn; Biörn I. Ivemark; Kalle Salo

Abstract. The fetal arterial vasculature of 36 normal human placentas was studied by microangiography. There are two fairly readily distinguishable types of intracotyledonary artery. The first intracotyledonary artery (type A) is long and narrow and runs straight from the chorionic space towards the decidua. Its branches run within the same stem in the same or the opposite direction. The second intracotyledonary artery (type B) is thicker and twisted, and its branches extend perpendicularly from the stem. According to the distribution of these two types of arteries, three different groups of cotyledons were distinguished—those with only type A arteries, those with only type B arteries, and those with both types of intracotyledonary arteries. In these mixed cotyledons the type B arteries were always situated in the middle of the cotyledon. A fourth cotyledonary group was also distinguished; it was composed of an irregular mixture of different types of arteries, which could often only be classified with difficulty. Recurrent anchoring arteries could definitely be demonstrated. These were always branches of type B intracotyledonary arteries. In 5 of the 36 placentas spiralling involved almost all the fetal placental arteries.


Journal of Immunology | 1988

Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.

Paolo Lusso; Phillip D. Markham; Annamari Ranki; Patricia L. Earl; Bernard Moss; F. Dorner; Robert C. Gallo; Kai Krohn


Proceedings of the National Academy of Sciences of the United States of America | 1987

Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men

Kai Krohn; W. G. Robey; S. Putney; L. Arthur; P. Nara; P. Fischinger; Robert C. Gallo; F. Wong-Staal; Annamari Ranki


The New England Journal of Medicine | 1988

Interpretation of antibodies reacting solely with human retroviral core proteins.

Annamari Ranki; Eija Johansson; Kai Krohn


Journal of Acquired Immune Deficiency Syndromes | 1993

Helper T-cell recognition of HIV-1 Tat synthetic peptides.

Blazevic; Annamari Ranki; Satu Mattinen; Sirkka-Liisa Valle; S. Koskimies; Günther Jung; Kai Krohn


AIDS | 1997

T-cell recognition of HIV antigens in HIV-seroreverted persons.

Annamari Ranki; Jukka Suni; Blazevic; Holmström P; Satu Mattinen; Kai Krohn; Sirkka-Liisa Valle

Collaboration


Dive into the Kai Krohn's collaboration.

Top Co-Authors

Avatar

Annamari Ranki

Helsinki University Central Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bernard Moss

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Paolo Lusso

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge